The use of central venous catheters has increased dramatically over the past 40 years [1] . These devices are essential for many clinical treatments including access for chemotherapy, antibiotics, and blood transfusions [2] . Indwelling catheters terminating in a port are particularly useful for intermittent treatment for malignancies [3] . Advantages include protection of the device from damage or infection by the overlying skin and a reduction in venipuncture injuries and infusion complications [1, 4, 5] . In this study, we investigated the Angiodynamics Vortex Smart Port Mini (Angiodynamic Inc, Manchester, GA). These ports were inserted into the upper arm with the tip of the attached catheter at the right atrial/superior vena cava junction. This particular arm port model is approved for power injection of computed tomography (CT) contrast agent, which has traditionally not been possible with other arm ports. Because arm ports are not typically used for contrast injection, the objective of this study was to evaluate the image quality of CTs obtained via arm port power injection compared with contrast injection of a peripheral vein.
Methods
We performed a retrospective cohort study of patients who had a power injectable arm port inserted between July 2013 and June 2014. Ethics approval for this study was obtained from our local biomedical research committee (University of Saskatchewan) and data review was in compliance with provincial and national privacy legislation.
Subjects were identified by reviewing a database of patients who had undergone contrast-enhanced CT (n ¼ 54). To reduce variability from timing of contrast bolus, we analysed only scans with a mixed phase of contrast (contrast present within the systemic arterial and portal venous systems). The inclusion criteria were patients who had a combined chest-abdomenpelvis CT scan via an arm port injection, and who also had a prior CT scan of the same type with injection via a peripheral arm vein. Therefore, each subject served as his or her own control. Eighteen subjects met these inclusion criteria.
CT images were reviewed on Philips iSite Radiology Picture Archive and Communication System (Koninklijke Philips Electronics, Best, The Netherlands). Scan dates ranged between July 2012 and July 2014 with CT slice thickness ranging from 3.8-5 mm and volume CT dose index ranging from 2.2-20.43 mGy. CT scans were from 4 acute care centres (Royal University Hospital, Saskatoon City Hospital, Cypress Regional Hospital, and Battlefords Union Hospital).
Assessment of objective image quality was performed by measuring signal-to-noise (SNR) and contrast-to-noise (CNR) ratios, as described by Heyer et al [6] . SNR and CNR were determined at 3 anatomical levels: 1) aortic arch; 2) main pulmonary artery (MPA) and right pulmonary artery (RPA); and 3) descending aorta and left atrium ( Figure 1 ). The following equations were used for each structure, where SI structure is signal intensity (SI) of a structure, SI muscle is mean SI of muscles, and BN is background noise: SNR structure ¼ SI structure /BN and CNR structure ¼ (SI structure -SI muscle )/BN. SI values were calculated by measuring regions of interest (ROI), which were positioned to include adequate cross-sectional area of structures and avoid noise such as fat and bone. Muscle groups used to measure SI included the right and left pectoralis major, infraspinatus, and serratus anterior muscles. A standard deviation of 3 ROIs in the surrounding air was used to determine background noise. Data analysis was performed using 2-tailed t tests in Microsoft Excel for Mac 2011 version 14.4.4 (Microsoft Corporation, Redmond, WA).
Results and Discussion
There were 18 subjects in our study (9 male, mean age 57.3 years [range 26-84 years]).
There was no significant difference in objective image quality as injection via arm port and via peripheral vein had similar SNR (29. 15 (Figure 2 ).
There were no statistically significant differences in objective image quality. We had expected a difference in that right atrial injection of the contrast via the arm port would allow the contrast bolus to remain compact in the venous system with less potential for dilution with unopacified blood. Moreover, we had expected less noise during the port injections, as we would be avoiding the contrast entering the chest en route from the axillary and subclavian veins and the superior vena cava. However, these potential advantages did not lead to a significant difference in terms of the objective image quality for our study group, likely because we evaluated a relatively delayed phase of imaging, which is the most common phase used for this group of patients.
There were limitations to our study. First, we performed comparison of CT images in the mixed phase of intravenous contrast enhancement. We suspect that the SNR and overall image quality would be better for the port group if the same comparison were performed for CT pulmonary embolism studies. We plan on exploring this question in future research. Second, this was a retrospective study and therefore we were not able to control for parameters such as CT scanner site, CT scanner design, protocols, and injection rates. There may have been variability in these parameters as we reviewed scans from 4 different acute care centres. Although this is a limitation, it also reflects realworld use of the port lines for injection in multiple centres. Last, all ROI values in the study were obtained from thoracic structures. While we cannot be certain that the same conclusion holds true for abdominal CT studies, we anticipate that this is the case as phase of contrast enhancement evaluated was relatively delayed, for this study. Therefore, technical changes would be required to apply this to abdominal studies. 
Conclusion
In conclusion, we found that there was no statistically significant difference in objective CT image quality for mixed phase contrast enhancement when contrast injection via peripheral vein was compared to power injection of an arm port. Power injection of a central venous catheter attached to an arm port is a safe and acceptable alternative strategy for contrast-enhanced CT [7, 8] . Our work demonstrates that contrast injection via port has equivalent image quality when compared to conventional peripheral intravenous injection technique.
